Quality Of Life Assessment of Covid-19 Patients with Pharmacoeconomics Perspective (Research Article)

Author(s): Mohammed Adnan Ali, G. Shireesha, N. Pranitha, Malvey Anusha Shree, and V. Asha Jyothi*

Abstract: BACKGROUND: Corona virus or SARS CoV-2 becomes a deadly infectious disease leading to severe respiratory distress causing mortality in older population and severe respiratory illness in adults and children. On 31st Jan 2020 WHO declares "A global health emergency" in worldwide & 11th mar 2020 as pandemic situation which is expected to be zoonotic in nature. The incubation period is 1-14 days & for second exposure up to 24 days The Quality of life of COVID 19 patients depends upon 4 primary dimensions (functional wellbeing, emotional wellbeing, social wellbeing) along with QOL domains, various assessments forms have also done like WHO questionnaires to analysed QOL in COVID 19 individuals. Pharmacoeconomics helps in analysing costs of drug therapy in health care system which causes health care burden to society. Various Pharmacoeconomics methods evaluates cost of treatment and treatment outcomes. This study explains about various costs associated in COVID19 treatment till its recovery/death. QOL assessment shows that need to be improved & Pharmacoeconomics aspects reveals that cost burden is more in covid positive individuals. METHODOLOGY: This is a prospective multicentric study carried out for a period of six months. The study included the covid positive and non-infected subjects. The subjects who have filled in the consent form are taken into the study and necessary data was collected through the telephonic interview, google forms. All the data that is documented in suitable data collection form and analyzed.

PAGES: 137-157  |  103 VIEWS  78 DOWNLOADS